Publications & metrics.

AI-enhanced therapeutic drug monitoring for vancomycin and β-lactam antibiotics in critical care: from population PK to bedside algorithms

A Z. Al Meslamani, A S. Jarab, E Merghani Ali Mohammed

Expert Review of Clinical Pharmacology, 2026

Biosimilars as antivirals: scientific and regulatory readiness for rapid, cost-effective deployment in infectious threats

A Z. Al Meslamani, A S. Jarab, E Merghani Ali Mohammed, et al

Expert Opinion on Biological Therapy, 2026

Community Pharmacists’ Role in Palliative Care: Evaluating Knowledge, Attitudes, Practices, and Perceived Barriers in the UAE

A Jarab, W Al-Qerem, R Elsherif, et al

Journal of Multidisciplinary Healthcare, 2026

Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) research in the Gulf Cooperation Council Countries: A mapping scoping review of epidemiology, clade, and research priority gaps

R H. Al-Rifai, S Taher, H Amoodi, et al

Journal of Infection and Public Health, 2026

Integrating Large Language Models Into UAE Community Pharmacies: Pharmacists′ Perspectives on Benefits, Concerns, and Implementation Barriers

A S. Jarab, A Z. Al Meslamani, W Al-Qerem, et al

International Journal of Telemedicine and Applications, 2026

Artificial intelligence tool utilization in deprescribing practices among community pharmacists in Jordan: a cross-sectional study

A Z. Al Meslamani, D Abu‐Naser, A S. Jarab, et al

Frontiers in Digital Health, 2026

Beyond the first switch: multiple switching, cross-switching, and nocebo-aware implementation of biosimilars in real-world care in non-US health systems

A Z. Al Meslamani, A S. Husam El Sharu, H El Sharu, et al

Expert Opinion on Biological Therapy, 2026

Biosimilar stewardship at the interface of disproportionality methods and AI integration: current evidence and potential strategies

A Z. Al Meslamani, A S. Jarab, E Merghani Ali Mohammed, et al

Expert Opinion on Biological Therapy, 2026

Biosimilars in practice: best-practice immunogenicity assessment and switching/interchangeability strategies for pharmacy-led programs

K Abouhait, A Z. Al Meslamani

Bioanalysis, 2026

Computational approaches to adverse outcome pathway networks: advances in construction, quantification, and regulatory decision support

A Abou Hajal, A Z. Al Meslamani

Computational Toxicology, 2026

Developability-by-design for bispecific antibodies in discovery: combining computational prediction and early screening for candidate selection

A Z. Al Meslamani, A S. Jarab, K Ahmed Al Marshoodi

Expert Opinion on Biological Therapy, 2026

Digital twins in precision pharmacotherapy: emerging applications, challenges, and future directions

A S. Jarab, W Al-Qerem, H Jarab, et al

Frontiers in Digital Health, 2026

Eleven-year trends in epidemiology, determinants, and antimicrobial resistance of major bacterial pathogens in Jordan: a retrospective surveillance study

A Z. Al Meslamani, D Abu‐Naser, A S. Jarab, et al

International Journal of Environmental Health Research, 2026

Exploring knowledge, attitudes, and preventive practices related to dengue fever control: a cross-sectional study of 1,016 individuals

A S. Jarab, W Al‐Qerem, A Z Al Meslamani, et al

Pathogens and Global Health, 2026

Factors associated with low-density lipoprotein control in outpatients with myocardial infarction: A hospital-based study

A S. Jarab, W Al-Qerem, R Mansour, et al

PLoS ONE, 2026

Harmonizing immunogenicity for AAV and LNP/mRNA modalities: best-practice panels for binding, neutralizing, and cellular assays with pre-existing immunity controls

A Z Al Meslamani, A S Jarab, E Merghani Ali Mohammed

Bioanalysis, 2026

Job satisfaction and its demographic, occupational, and mental health determinants among community pharmacists

A S. Jarab, A Z. Al Meslamani, W Al-Qerem, et al

PLoS ONE, 2026

Mpox knowledge, anxiety, and preventive behaviours in Jordan: a socio‑ecological perspective on vaccination and preparedness

A Z. Al Meslamani, D Abu‐Naser, E Merghani Ali Mohammed

International Journal of Environmental Health Research, 2026

Pharmacists, knowledge and counseling practices regarding tirzepatide for obesity and type 2 diabetes management in the UAE

A S. Jarab, J Abdallah, W Al Qerem, et al

Pharmacy Practice, 2026

Public knowledge, attitudes, and barriers to cancer screening in the UAE: a comprehensive assessment to inform screening practices

A S. Jarab, W Al-Qerem, H Jarab, et al

Frontiers in Public Health, 2026

Understanding Gaps in Pharmacist–Patient Role Perceptions: Implications for Collaborative Care

A Jarab, W Al‐Qerem, A Alzoubi, et al

Journal of Multidisciplinary Healthcare, 2026

Readiness, knowledge, and attitudes of healthcare professionals in Jordan toward Monkeypox: a cross-sectional survey

A Z. Al Meslamani, D Abu‐Naser, R H. Al‐Rifai

Scientific Reports, 2025

Management of polypharmacy through deprescribing in older patients: a review of the role of AI tools

A Z. Al Meslamani

Expert Review of Clinical Pharmacology, 2025

Biosimilars and immunogenicity: a matter of concern?

A S. Jarab, S Abu Heshmeh, A Z. Al Meslamani

Expert Opinion on Drug Safety, 2025

Language models for drug–drug interactions: current applications, pitfalls, and future directions

A Z. Al Meslamani, A Abou Hajal

Expert Opinion on Drug Metabolism & Toxicology, 2025

Utilization, perceived benefits and concerns regarding robotic technologies among community pharmacists

A S. Jarab, A Z. Al Meslamani, W Al‐Qerem, et al

Future Science OA, 2025

Assessing Knowledge and Awareness of Asthma and Chronic Obstructive Pulmonary Disease Among the Iraqi Population

A Hussein Alsajri, W Al‐Qerem, A S. Jarab, et al

International Journal of COPD, 2025

Evaluating the Use of Inhaled Budesonide and Ipratropium Bromide Combination in Patients at High Risk of Acute Respiratory Distress Syndrome Development: A Randomized Controlled Trial

H Ahmed Mohamed Moustafa, F H. Elbery, A Z. Al Meslamani, et al

Pharmaceuticals, 2025

The Role of Pharmacists in Public Health and Disease Prevention: What Do We Know?

A Z. Al Meslamani

Clinical Pharmacy Connect, 2025

Assessment of contraceptive use and side effects among women in five countries across the Middle East: a cross-sectional study

A Ramadan, A S. Jarab, A Z. Al Meslamani, et al

Current Medical Research and Opinion, 2025

Before you start: the safety of SGLT2 inhibitors for anti-obesity treatment

A Z. Al Meslamani

Expert Opinion on Drug Safety, 2025

Community pharmacists’ knowledge, attitudes, and concerns about POCT in the UAE: a cross-sectional study

A S. Jarab, W Al‐Qerem, A Z. Al Meslamani, et al

Future Science OA, 2025

Gut–lung axis and microbiome interplay in type 2 high asthma

A Z. Al Meslamani

Expert Review of Respiratory Medicine, 2025

Investigating the point prevalence, types, severity, causes and predictors of vaccines administration errors during COVID-19 pandemic in Jordan

D H. Abdel‐Qader, H Abdel-Qader, J Silverthorne, et al

PLoS ONE, 2025

Knowledge, Attitudes, and Practices of Community Pharmacists Regarding Proton Pump Inhibitor (PPI) Use: A Cross-Sectional Study

H Ahmed Mohamed Moustafa, A Z. Al Meslamani, H Ahmed, et al

Healthcare, 2025

Spatially resolved airway niches: mapping epithelial–immune microenvironments in asthma

M Sakkal, A S. Jarab, A Z. Al Meslamani

Expert Review of Respiratory Medicine, 2025

Advances in type 2-high asthma therapy: what remains missing?

A Z. Al Meslamani, A S. Jarab, A Elrefae

Expert Review of Respiratory Medicine, 2025

Augmenting immunogenicity workflows with AI and real-world evidence: failure points, tools, and a closed-loop operational blueprint

A Z. Al Meslamani, A S. Jarab, E Merghani Ali Mohammed

Bioanalysis, 2025

Hurdles in the personalized medicine implementation path: public’s literacy and misconceptions of whole genomic sequencing test

A Ramadan, A S. Jarab, A Z. Al Meslamani, et al

Critical Public Health, 2025

Occupational determinants of anxiety, depression, and stress among community pharmacists in Jordan: a cross-sectional study

A S. Jarab, W Al‐Qerem, A Z. Al Meslamani

Psychology Health & Medicine, 2025

Prevalence and reporting of adverse drug events among women in Jordan

A Z. Al Meslamani, D Abu‐Naser, A Baroudi

International Journal of Pharmacy Practice, 2025

The Impact of a Community Pharmacy-Led Deworming-Related Counselling Service: An Interventional Study in a Low-to-Middle Income Country

A B. Kassem, A Z. Al Meslamani, M Abdelrahman, et al

Tropical Medicine and Infectious Disease, 2025

Machine learning in infectious diseases: potential applications and limitations

A Z. Al Meslamani, I Sobrino, J de la Fuente

Review of machine learning applications in infectious-disease management. Catalogues where ML actually pays off in clinical decision making and where evaluation methodology still lags behind.

Annals of Medicine, 2024

Bridging the gap: The future of biosimilars regulations

A S. Jarab, S Abu Heshmeh, A Z. Al Meslamani

Human Vaccines & Immunotherapeutics, 2024

Why are digital health policies crucial?

A Z. Al Meslamani

Journal of Medical Economics, 2024

Insights into artificial intelligence utilisation in drug discovery

A Abou Hajal, A Z. Al Meslamani

Journal of Medical Economics, 2024

Policy solutions for medication non-adherence: what can governments do?

A Z. Al Meslamani

Expert Review of Pharmacoeconomics & Outcomes Research, 2024

Challenges in health economics research: insights from real-world examples

A Z. Al Meslamani

Journal of Medical Economics, 2024

Short and long-term economic implications of biosimilars

A Z. Al Meslamani

Expert Opinion on Biological Therapy, 2024

The pharmacists’ interventions after a Drug and Therapeutics Committee (DTC) establishment during the COVID-19 pandemic

A B. Kassem, A Z. Al Meslamani, D H. Elmaghraby, et al

Journal of Pharmaceutical Policy and Practice, 2024

Barriers to digital endpoints in data collection in low and middle-income countries

A Z. Al Meslamani

Expert Review of Pharmacoeconomics & Outcomes Research, 2024

Adverse drug event reporting among women: uncovering disparities in underserved communities

A Z. Al Meslamani

Expert Opinion on Drug Safety, 2024

Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice

A Ramadan, A S. Jarab, A Z. Al Meslamani

Human Genomics, 2024

Disparities in drug safety practices in developing nations: focusing on underlying factors and implications for global health

A Z. Al Meslamani, D H. Abdel‐Qader, A B. Kassem, et al

Expert Opinion on Drug Safety, 2024

Knowledge, Attitudes, and Practices (KAP) of community pharmacists regarding antibiotic use and resistance: a cross-sectional study from the United Arab Emirates

T Qudah, M Ahmad Alameri, A Alqudah, et al

International Journal of Environmental Health Research, 2024

Barriers to transforming community pharmacies into point-of-care testing sites in low- and middle-income countries

A S. Jarab, S Abu Heshmeh, A Z. Al Meslamani

International Journal of Pharmacy Practice, 2024

Biosimilars as antivirals: opportunities and challenges

A S. Jarab, S Abu Heshmeh, A Z. Al Meslamani

Expert Review of Anti-infective Therapy, 2024

Decoding treatment efficacy: uncovering response and failure dynamics to biologics in asthma

A Z. Al Meslamani

Expert Opinion on Biological Therapy, 2024

Examining the impact of biosimilar-to-biosimilar transition on effectiveness and safety

A S. Jarab, S Abu Heshmeh, A Z. Al Meslamani

Expert Opinion on Biological Therapy, 2024

Beyond resistance: assessing sulbactam-durlobactam’s role in today’s clinical landscape

A Z. Al Meslamani

Expert Review of Anti-infective Therapy, 2024

Is the world crippled by antimicrobial resistance, or simply lacking information?

A Z. Al Meslamani

Expert Review of Anti-infective Therapy, 2024

Assessing the economic impact of digital endpoints on medication adherence

A Z. Al Meslamani, N Li

Expert Review of Pharmacoeconomics & Outcomes Research, 2024

The long-term clinical impact of digital endpoints and biomarkers in data collection

A Z. Al Meslamani

Expert Review of Pharmacoeconomics & Outcomes Research, 2024

Understanding patient variability to biologic treatments in inflammatory bowel disease

A Z. Al Meslamani

Expert Opinion on Biological Therapy, 2024

Why are outcome-based drug safety research studies scarce? Insights into operational challenges and potential solutions

A Z. Al Meslamani

Expert Opinion on Drug Safety, 2024

Antiretroviral therapy response: exploring the potential influence of SARS-CoV-2

A Z. Al Meslamani

Expert Review of Clinical Pharmacology, 2024

Navigating the crossroads: asthma, trained immunity, and infection susceptibility

A Z. Al Meslamani, E Merghani Ali

Expert Review of Clinical Immunology, 2024

Technical and regulatory challenges of digital health implementation in developing countries

A Z. Al Meslamani

Maps the technical and regulatory obstacles that slow digital-health rollouts in low- and middle-income countries, with concrete suggestions for closing the policy-to-practice gap.

Journal of Medical Economics, 2023

Underreporting of Adverse Drug Events: a Look into the Extent, Causes, and Potential Solutions

A Z. Al Meslamani

An honest look at why so many adverse drug events go unreported, what the under-reporting actually costs patients, and concrete policy moves that could close the gap.

Expert Opinion on Drug Safety, 2023

Applications of AI in pharmacy practice: a look at hospital and community settings

A Z. Al Meslamani

Companion piece to the AI-in-pharmacy overview. Focuses on the operational differences between hospital and community-pharmacy AI deployments, including data-governance constraints.

Journal of Medical Economics, 2023

Artificial intelligence (AI) in pharmacy: an overview of innovations

A S. Jarab, S Abu Heshmeh, A Z. Al Meslamani

Practical survey of AI applications already in use across pharmacy practice. Sorted by what works in community pharmacies versus hospital settings, with realistic adoption barriers called out.

Journal of Medical Economics, 2023

Beyond implementation: the long-term economic impact of AI in healthcare

A Z. Al Meslamani

Looks past the deployment headline and asks the question hospital administrators actually need answered: what is the long-term economic impact of AI tooling on health-system budgets.

Journal of Medical Economics, 2023

Antibiotic resistance in low- and middle-income countries: current practices and its global implications

A Z. Al Meslamani

Review article on antibiotic stewardship from the clinical-pharmacy perspective, mapping where pharmacist-led stewardship interventions have measurable effects on prescribing patterns.

Expert Review of Anti-infective Therapy, 2023

Medication errors during a pandemic: what have we learnt?

A Z. Al Meslamani

Expert Opinion on Drug Safety, 2023

Gaps in digital health policies: an insight into the current landscape

A Z. Al Meslamani

Journal of Medical Economics, 2023

Real-World Effectiveness of Four Types of COVID-19 Vaccines

D H. Abdel‐Qader, H Abdel-Qader, J Silverthorne, et al

Vaccines, 2023

The future of precision medicine in oncology

A Z. Al Meslamani

Expert Review of Precision Medicine and Drug Development, 2023

The Abuse and Misuse of Over-the-Counter Medicines During COVID-19

A Z. Al Meslamani, D H. Abdel‐Qader

Hospital Pharmacy, 2023

How AI is advancing asthma management? Insights into economic and clinical aspects

A Z. Al Meslamani

Journal of Medical Economics, 2023

Antibody-drug conjugates in oncology: insights into Current challenges

A Z. Al Meslamani, M F. Bostanudin

Expert Opinion on Biological Therapy, 2023

Overcoming barriers to machine learning applications in toxicity prediction

A Abou Hajal, A Z. Al Meslamani

Expert Opinion on Drug Metabolism & Toxicology, 2023

Assessment of Knowledge and attitude towards Stroke among the UAE population during the COVID-19 pandemic: A cross-sectional study

A Ramadan, Z Kharaba, R Ghemrawi, et al

F1000Research, 2023

How does sleep influence asthma through immunity?

A Z. Al Meslamani

Expert Review of Clinical Immunology, 2023

The role of machine learning in healthcare responses to pandemics: maximizing benefits and filling gaps

A Z. Al Meslamani, A S. Jarab, M A. Ghattas

Journal of Medical Economics, 2023

Advancing towards a worldwide healthcare system in the post-COVID-19 era: benefits and barriers to international collaboration in healthcare

A Z. Al Meslamani

Journal of Medical Economics, 2023

Insights into the immunological links between dietary habits and asthma

A Z. Al Meslamani

Expert Review of Clinical Immunology, 2023

Adoption of electronic patient medication records in community pharmacies in the United Arab Emirates: A cross-sectional survey

A Z. Al Meslamani, A S. Jarab, D H. Abdel‐Qader, et al

Health Information Management Journal, 2023

How climate change influences pathogen transmission

A Z. Al Meslamani

Pathogens and Global Health, 2023

What hinders individualized therapy plans for asthma patients?

A Z. Al Meslamani

Expert Opinion on Pharmacotherapy, 2023

Assessment of changes in the epidemiology and prognosis of non-SARS-CoV-2 respiratory infections one year after recovery from COVID-19

A Z. Al Meslamani, N Sammani

Respiratory Investigation, 2023

Strategies for reducing chronic disease burden during pandemics

A Z. Al Meslamani

Current Medical Research and Opinion, 2023

Pharmacokinetic interaction of rosuvastatin with artichoke (Cynara scolymus L.) leaf extract in rats

A M. Al Masalmeh, E Mallah, K Mansoor, et al

Journal of Applied Pharmaceutical Science, 2023

Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?

A Z. Al Meslamani

Expert Review of Clinical Immunology, 2023

Are we aware of stroke risk factors and warning signs amid COVID-19? Knowledge and attitude towards risk-factors, signs and symptoms of stroke among the UAE population during COVID-19 pandemic: A cross-sectional study

A Ramadan, Z Kharaba, R Ghemrawi, et al

F1000Research, 2023

Economic benefits of global Collaborative Health technology

A Z. Al Meslamani

Expert Review of Pharmacoeconomics & Outcomes Research, 2023

The economic impact of pharmacist intervention during pandemics

A Z. Al Meslamani, A S. Jarab

Expert Review of Pharmacoeconomics & Outcomes Research, 2023

The patterns and determinants of telemedicine use during the COVID-19 crisis: A nationwide study

A Z. Al Meslamani, R Aldulaymi, H El Sharu, et al

Cross-sectional study of how telemedicine adoption shifted during the COVID-19 crisis. Identifies the patterns and determinants that predicted whether clinicians stuck with virtual care after the acute phase.

Journal of the American Pharmacists Association, 2022

Caffeine Consumption among Various University Students in the UAE, Exploring the Frequencies, Different Sources and Reporting Adverse Effects and Withdrawal Symptoms

Z Kharaba, N Sammani, S Ashour, et al

Multi-country survey of caffeine consumption among university students in the UAE, including the awareness gap around the consumption-and-health-effect link.

Journal of Nutrition and Metabolism, 2022

Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan

D H. Abdel‐Qader, H Abdel-Qader, J Silverthorne, et al

Clinical Drug Investigation, 2022

What has changed in the pharmaceutical care after COVID-19: Pharmacists’ perspective

Z Kharaba, S A. Moutraji, R A Al Khawaldeh, et al

Cross-sectional survey of UAE community pharmacists on perceived benefits, barriers, and adoption concerns around electronic patient medication record systems beyond hospital settings.

Pharmacy Practice, 2022

IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine

D H. Abdel‐Qader, I Hazza Alkhatatbeh, W Hayajneh, et al

Vaccine, 2022

The impact of telepharmacy on hypertension management in the United Arab Emirates

O Mohamed Ibrahim, A Z. Al Meslamani, R Ibrahim, et al

Pharmacy Practice, 2022

Papain-Decorated Mucopenetrating SEDDS: A Tentative Approach to Combat Absorption Issues of Acyclovir via the Oral Route

A Mahmood, R Haneef, A Z. Al Meslamani, et al

Pharmaceutics, 2022

A Comparative Cross-Sectional Study- Knowledge, behavior and psychological change among Medical and Non-medical Students in Jordan during COVID-19 pandemic

E Ebraheem Al Jomaa, A Al Meslamani, H Abazid

Jordan Journal of Pharmaceutical Sciences, 2022

Evaluating the impact of COVID-19 on mental health of the public in Jordan: A cross-sectional study

Y A. Suleiman, D H. Abdel‐Qader, B A. Suleiman, et al

Journal of Pharmacy & Pharmacognosy Research, 2022

The Effectiveness of Pharmacist-Based Coaching in Improving Breast Cancer-Related Health Behaviors: A Randomized Controlled Trial

O Mohamed Ibrahim, N A. El-Bassiouny, E Abdelhameed Dergham, et al

Pharmacy Practice, 2022

The patterns of herbal medicine use in the United Arab Emirates; A national study

N Al Mazrouei, A Z. Al Meslamani, R Alajeel, et al

Pharmacy Practice, 2022

Systematic review of the safety and efficacy of antazoline in the treatment of atrial fibrillation

R Aldulaymi, A Z. Al Meslamani

Journal of Pharmacy & Pharmacognosy Research, 2022

Assessment of A new Strategy to Prevent Prescribing Errors Involving COVID-19 Patients in Community Pharmacies

D H. Abdel‐Qader, A Z. Al Meslamani, A Albassam, et al

Hospital Pharmacy, 2022

Antibiotic prescribing errors generated by the use of an electronic prescribing system in the emergency department: A mixed-method study

A Z. Al Meslamani, D H. Abdel‐Qader, N Ziad, et al

Journal of Pharmacy & Pharmacognosy Research, 2022

Experience, Satisfaction, Attitude, and Challenges of Virtual Learning amongst Undergraduate Students of Management and Science University (MSU) during MCO.

S Fei Tan, K Wen Ng, C Choon Wong, et al

Journal of management & science, 2022

The role of professional socialisation in reducing drug-related problems during COVID-19: a new insight for future pandemics

A Z. Al Meslamani

Drugs & Therapy Perspectives, 2022

The rewarding challenges of providing health care in a remote area

Z Woodward, F Zhou

Journal of the American Pharmacists Association, 2022

An emergency plan for management of COVID‐19 patients in rural areas

A Z. Al Meslamani, A B. Kassem, N A. El‐Bassiouny, et al

Practical emergency-management framework for COVID-19 patient care in rural areas, written for clinical teams operating with limited infrastructure.

International Journal of Clinical Practice, 2021

Pharmacists-physicians collaborative intervention to reduce vaccine hesitancy and resistance: A randomized controlled trial

D H. Abdel‐Qader, W Hayajneh, A Albassam, et al

Pharmacist-physician collaborative intervention designed to reduce vaccine hesitancy. Reports the effect size, the trust-building moves that worked, and the ones that did not.

Vaccine X, 2021

Virtual pharmacist interventions on abuse of over-the-counter medications during COVID-19 versus traditional pharmacist interventions

N Al Mazrouei, R Ibrahim, A Z. Al Meslamani, et al

Virtual pharmacist intervention study during COVID-19 lockdown. Evaluates whether telephone- and video-based counselling reduced over-the-counter medication misuse.

Journal of the American Pharmacists Association, 2021

Knowledge, Attitudes, and Practices Concerning Breast Cancer and Self Examination Among Females in UAE

Z Kharaba, M Buabeid, A Ramadan, et al

Journal of Community Health, 2021

Assessment of Extrapyramidal Symptoms Associated with Psychotropics Pharmacological Treatments, and Associated Risk Factors

D Abu‐Naser, S Gharaibeh, A Z. Al Meslamani, et al

Clinical Practice and Epidemiology in Mental Health, 2021

Virtual Coaching Delivered by Pharmacists to Prevent COVID-19 Transmission

D H. Abdel‐Qader, A Z. Al Meslamani, N Al Mazrouei, et al

Hospital Pharmacy, 2021

Pharmacy students' knowledge and attitude of prescribing errors

A Z. Al Meslamani, D H. Abdel‐Qader, A Albassam, et al

Journal Of Advanced Pharmacy Education And Research, 2021

Assessment of inappropriate prescribing of QT interval-prolonging drugs in end-stage renal disease patients in Jordan

A Z. Al Meslamani, D Abu‐Naser, D H. Abdel‐Qader, et al

Drugs & Therapy Perspectives, 2021

A novel educational approach for improving medication-related problems in community pharmacies

N Al Mazrouei, R Ibrahim, A Z. Al Meslamani, et al

Research in Social and Administrative Pharmacy, 2021

Assessment of a new strategy for catalyzing deprescribing in community pharmacies

O Mohamed Ibrahim, N Al Mazrouei, A Z. Al Meslamani, et al

Journal of the American Pharmacists Association, 2021

Benchmarking clinical pharmacy services in the United Arab Emirates with United States of America and Sweden

R Haider Al Zahawi, M Rafi Baig, T Dixon, et al

Journal of Pharmacy & Pharmacognosy Research, 2021

Development of a multivariable model to predict medication non-adherence risk factor for patients with acute coronary syndrome

A Sadeq, A Ahmed Elnour, A Hamrouni, et al

Journal of Pharmaceutical Health Services Research, 2021

The effect of educational interventions on medication dispensing errors: a randomised controlled trial in community pharmacies in Jordan

D H. Abdel‐Qader, A Z. Al Meslamani, N Al Mazrouei, et al

Drugs & Therapy Perspectives, 2021

Applying medicines reconciliation indicators in two UK hospitals: a feasibility study

M Aljamal, D H. Abdel‐Qader, A Z. Al Meslamani

Journal of Pharmaceutical Health Services Research, 2021

Evaluating psychiatrists’ attitudes and expectations about pharmacists’ role in psychiatry in Jordan

D H. Abdel‐Qader, E Ebraheem Al Jomaa, J Silverthorne, et al

Journal of Pharmaceutical Health Services Research, 2021

Hydroxyurea for the Management of Sickle Cell Disease: Assessment of Effectiveness and Side Effects

International Journal of Pharmaceutical Research, 2021

Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors

O Mohamed Ibrahim, R Ibrahim, A Z. Al Meslamani, et al

Journal of Telemedicine and Telecare, 2020

Evaluation of Telepharmacy Services in Light of COVID-19

O Mohamed Ibrahim, R Ibrahim, D H. Abdel‐Qader, et al

One of the earliest evaluations of telepharmacy services rolled out during COVID-19. Documents what worked, what failed, and the regulatory questions that emerged from pharmacist-led virtual care in the UAE.

Telemedicine Journal and e-Health, 2020

Incidence, nature, severity, and causes of dispensing errors in community pharmacies in Jordan

D H. Abdel‐Qader, A Z. Al Meslamani, P Lewis, et al

Prospective audit of dispensing-error rates, types, and severity in UAE community pharmacies, with a clinical-significance assessment for each error category.

International Journal of Clinical Pharmacy, 2020

Dispensing errors in community pharmacies in the United Arab Emirates: investigating incidence, types, severity, and causes

O Mohamed Ibrahim, R Ibrahim, A Z. Al Meslamani, et al

Prospective study of dispensing errors in UAE community pharmacies. Reports incidence, contributing factors, and the structural changes that would meaningfully reduce error rates.

Pharmacy Practice, 2020

Knowledge and Beliefs of Jordanian Community Toward E-cigarettes: A National Survey

D H. Abdel‐Qader, A Z. Al Meslamani

National survey of Jordanian community knowledge and beliefs about e-cigarettes. Reports the awareness gaps and the policy implications for tobacco-control programmes.

Journal of Community Health, 2020

The Role of Clinical Pharmacy in Preventing Prescribing Errors in the Emergency Department of a Governmental Hospital in Jordan: A Pre-Post Study

D H. Abdel‐Qader, N Saadi Ismael, A Z. Al Meslamani, et al

Hospital pharmacy intervention study showing that pharmacist-led review at the prescribing stage prevented a meaningful share of prescribing errors in the emergency department.

Hospital Pharmacy, 2020

The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge

N Al Mazrouei, R Ibrahim, A Z. Al Meslamani, et al

Assessment of how the role of UAE community pharmacists evolved through the early COVID-19 period, focusing on patient-counselling and triage responsibilities that crossed traditional scope-of-practice lines.

International Journal of Pharmacy Practice, 2020

Investigating prescribing errors in the emergency department of a large governmental hospital in Jordan

D H. Abdel‐Qader, A Z. Al Meslamani, A A. El-Shara, et al

Journal of Pharmaceutical Health Services Research, 2020

Herbal medicine use in the Jordanian population: A nationally representative cross-sectional survey

D H. Abdel‐Qader, A Albassam, N Saadi Ismael, et al

Journal of Pharmacy & Pharmacognosy Research, 2020

Community pharmacists’ knowledge of and attitudes toward antibiotic use, resistance, and self-medication in Jordan

D H. Abdel‐Qader, A Albassam, N Saadi Ismael, et al

Drugs & Therapy Perspectives, 2020

Pharmacy students’ attitude towards providing pharmaceutical care to patients with anxiety and their knowledge of psychotropic medicines in Jordan

E Ebraheem Al Jomaa, D H. Abdel‐Qader, J Silverthorne, et al

International Journal of Pharmacy Practice, 2020